Work

A Phase II Study of Sagopilone (ZK 219477; ZK-EPO) in Patients With Breast Cancer and Brain Metastases

Year: 2011

Type: article

Study design: Clinical Trial

Source: Clinical Breast Cancer

DOI: 10.1016/j.clbc.2011.03.024

Authors: Rachel A. Freedman, Elizabeth Bullitt, Lixian Sun, Rebecca Gelman, Gordon Harris, Jennifer A. Ligibel, Ian E. Krop, Ann H. Partridge, Emily Eisenberg, Eric P. Winer, Nancy U. Lin

Institutions: Harvard University, Dana-Farber Cancer Institute, University of North Carolina at Chapel Hill, Massachusetts General Hospital

Language: English

Topic: Brain Metastases and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Dana-Farber/Harvard Cancer Center, National Institutes of Health, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering

Awards: G1295147849, G4258809411, G4561983161, 3D Cerebral Vessel Location for Surgical Planning, G5544403951, Noninvasive assessment of tumor malignancy, G851536905

OpenAlex ID: W1984573641

FWCI: 5.687

Cites: 43

Cited by: 44

Related to: 10